IFNE, one of the 9p21 type-I interferons (Fig. 1a), is a tumor suppressor in ovarian cancer10, and IFNE treatment promotes CD8+ T cell activation while reducing T regulatory cells (Treg cells) and myeloid-derived suppressor cells (MDSCs)10. The gene discussed is IFNE; the disease is neoplasm.